compounded semaglutide crackdown news today Hims to stop offering GLP-1 pill after FDA warned of Compounded Semaglutide: What to Know

Microvasc Res (2012) 84(3):3958

Only rodent studies have shown an increased risk of medullary thyroid carcinoma

Mochi providers help members explore GLP-1 and other clinically backed treatments with personalized plans designed for sustainable weight loss and long-term support

Discover if you qualify for Brellos competitive GLP-1 Plans

The Patent Cliff Is Coming And That Changes Everything The patents for semaglutide are expected to expire in India in January 2026, opening the market for generic alternatives

Avoid Repeated Freeze-Thaw Cycles : Once reconstituted, aliquot the peptide into smaller portions and store them at -20C to maintain its integrity